Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products. | Sun Pharma Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. | ||||
Founding Date | Founding Date 1972 | Founding Date 2018 | Founding Date 1978 | Founding Date 1983 | Founding Date 1971 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Rapperswil-Jona, CH HQ | Locations El Segundo, US HQ | Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more | Locations Mumbai, IN HQ | Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more |
Employees | Employees 353% increase | Employees 2 | Employees 9,100 | Employees 43,000 | Employees 15,718 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.9b (FY, 2023) | Revenue (est.) ₹477.6b (FY, 2024) | Revenue (est.) ₹105.6b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.2b (FY, 2023) | Cost of goods ₹114.4b (FY, 2024) | Cost of goods ₹27.9b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $1.7b (FY, 2023) | Gross profit ₹371.7b (FY, 2024) | Gross profit ₹79.4b (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income $192m (FY, 2023) | Net income ₹96.5b (FY, 2024) | Net income ₹16.6b (FY, 2024) |